A prospective, interventional study of the Golazo Peripheral Atherectomy System for PAD

Study Description

Evaluating the Safety and Effectiveness of the Golazo Peripheral Atherectomy System for Treating Peripheral Artery Disease

Study Details

Registry ID:

NCT06321575

Conditions:

Peripheral Arterial Disease

Phase:

Not Applicable

Target Enrollment:

159 participants

Start Date:

June 20, 2024

Age Range:

18–999 years

Healthy Volunteers:

No

Study Locations (18 sites)

• Vascular Breakthroughs
  Plymouth, MassachusettsUnited States, United States
• Amavita Research Services
  Miami, FloridaUnited States, United States
• Palm Vascular Center
  Fort Lauderdale, FloridaUnited States, United States
• Advanced Heart and Vascular Institute
  Flemington, New JerseyUnited States, United States
• First Coast Cardiovascular Institute
  Jacksonville, FloridaUnited States, United States
• Spartanburg Regional Medical Center
  Spartanburg, South CarolinaUnited States, United States
• Tennessee Center for Clinical Trials
  Tullahoma, TennesseeUnited States, United States
• Cardiovascular Institute of the South - Houma
  Houma, LouisianaUnited States, United States
• Baton Rouge General Hospital
  Baton Rouge, LouisianaUnited States, United States
• Cardiovascular Institute of the South - Lafayette
  Lafayette, LouisianaUnited States, United States
• Bellin Health
  Green Bay, WisconsinUnited States, United States
• Nextstage Clinical Research - Beaumont
  Beaumont, TexasUnited States, United States
• Hope Vascular & Podiatry
  Houston, TexasUnited States, United States
• Nextstage Clinical Research - Waco
  Waco, TexasUnited States, United States
• Pulse Cardiovascular Institute
  Scottsdale, ArizonaUnited States, United States
• Merced Vascular
  Merced, CaliforniaUnited States, United States
• Pacific Vascular Institute
  ‘Aiea, HawaiiUnited States, United States
• Pacific Vascular Institute
  'Aiea, HawaiiUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →